(Q46146946)

19 December 2017

title

Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage (English)

1 reference

19 December 2017

author name string

Elif Tatlidede

1

1 reference

19 December 2017

Ozer Sehirli

2

1 reference

19 December 2017

Ayliz Velioğlu-Oğünc

3

1 reference

19 December 2017

Sule Cetinel

4

1 reference

19 December 2017

Berrak C Yeğen

5

1 reference

19 December 2017

Aysen Yarat

6

1 reference

19 December 2017

Selami Süleymanoğlu

7

1 reference

19 December 2017

Göksel Sener

8

1 reference

19 December 2017

publication date

23 January 2009

1 reference

19 December 2017

published in

Free Radical Research

1 reference

19 December 2017

volume

43

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

page(s)

195-205

1 reference

19 December 2017

Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Adriamycin-induced heart failure: mechanism and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Early changes in myocardial antioxidant enzymes in rats treated with adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Cardiovascular protective effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Biological effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Molecular mechanism of the chemopreventive effect of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Protective effect of resveratrol against oxidative stress in cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Protective effect of resveratrol against renal oxidative stress in cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Resveratrol, a red wine constituent polyphenol, protects from ischemia-reperfusion damage of the ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Effects of a phenolic compound, resveratrol, on the renal function and costimulatory adhesion molecule CD86 expression in rat kidneys with ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Hypercholesterolemia increases endothelial superoxide anion production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Functional consequences of oxidative membrane damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Catechin and proanthocyanidin B4 from grape seeds prevent doxorubicin-induced toxicity in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Erdosteine prevents doxorubicin-induced cardiotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Sheng-mai-san reduces adriamycin-induced cardiomyopathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Oxidative damage to DNA in mammalian chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Oxidative damage and mitochondrial decay in aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Doxorubicin-induced persistent oxidative stress to cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Effects of hypochlorous acid on unsaturated phosphatidylcholines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: a structure-activity relationship study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Anthracycline glycoside-membrane interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

Transesophageal Echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802673008

10.1080/10715760802673008

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017